Dicerna Pharmaceuticals Inc·4

Jun 16, 6:02 PM ET

Dicerna Pharmaceuticals Inc 4

4 · Dicerna Pharmaceuticals Inc · Filed Jun 16, 2017

Insider Transaction Report

Form 4
Period: 2017-06-15
ROSSKAMP RALF
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2017-06-15+250,000250,000 total
    Exercise: $2.91Exp: 2027-06-15Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]The option vests 25% on the first year anniversary of the vesting start date of June 15, 2017 and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject in each case to the reporting person's continued employment with the issuer through the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION